Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANKRD18A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM98B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CISD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GCDH - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAMP2-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
BORA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PTPN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMC4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KLHDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDC27 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPR137 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACLY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STK17B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GAT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VDAC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUSP12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on